Mead Johnson Nutrition CO (NYSE:MJN) has earned a consensus rating of “Hold” from the fifteen analysts that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $82.50.

A number of equities analysts have weighed in on MJN shares. BMO Capital Markets reaffirmed a “hold” rating and set a $90.00 price target on shares of Mead Johnson Nutrition CO in a research report on Thursday, June 15th. BidaskClub raised Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating in a report on Wednesday, June 14th. Zacks Investment Research downgraded Mead Johnson Nutrition CO from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Finally, Canaccord Genuity reissued a “speculative buy” rating on shares of Mead Johnson Nutrition CO in a report on Wednesday, July 5th.

Mead Johnson Nutrition CO (NYSE MJN) traded down 0.01% during midday trading on Tuesday, hitting $89.98. 11,923,467 shares of the stock traded hands. The company has a 50-day moving average price of $89.62 and a 200-day moving average price of $84.34. Mead Johnson Nutrition CO has a 1-year low of $69.25 and a 1-year high of $94.40.

COPYRIGHT VIOLATION NOTICE: “Mead Johnson Nutrition CO (MJN) Receives $82.50 Consensus PT from Brokerages” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/25/mead-johnson-nutrition-co-mjn-receives-82-50-consensus-pt-from-brokerages.html.

Several hedge funds have recently made changes to their positions in the stock. Meeder Asset Management Inc. purchased a new stake in shares of Mead Johnson Nutrition CO during the first quarter worth approximately $106,000. Oppenheimer Asset Management Inc. purchased a new stake in shares of Mead Johnson Nutrition CO during the first quarter worth approximately $120,000. Creative Planning raised its stake in shares of Mead Johnson Nutrition CO by 4.3% in the first quarter. Creative Planning now owns 2,169 shares of the company’s stock worth $193,000 after buying an additional 89 shares during the last quarter. Fiduciary Trust Co. purchased a new stake in shares of Mead Johnson Nutrition CO during the first quarter worth approximately $205,000. Finally, St. Louis Trust Co purchased a new stake in shares of Mead Johnson Nutrition CO during the first quarter worth approximately $212,000. 88.40% of the stock is currently owned by hedge funds and other institutional investors.

About Mead Johnson Nutrition CO

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Analyst Recommendations for Mead Johnson Nutrition CO (NYSE:MJN)

Receive News & Stock Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related stocks with our FREE daily email newsletter.